Skip to main content
Great Lakes NeuroTechnologies logo

Great Lakes NeuroTechnologies

Cleveland, OhioFounded 2010

  • Wearables
  • Parkinson's disease

Great Lakes NeuroTechnologies develops wireless and mobile medical technologies for remote patient monitoring, combining wearable sensors with mobile apps and web applications. Its Kinesia ONE system remotely measures movement symptoms associated with Parkinson’s disease and essential tremor, providing objective scores through a secure web portal for clinical care and research.

Raised
$4M
Investors
2
Founded
2010
Employees
11–50

reccy insights

Recent highlights

On Aug 28, 2025, Great Lakes NeuroTechnologies received a $2.1 million NIH SBIR grant, with the National Institute of Neurological Disorders and Stroke identified as lead investor, to support its deep-brain stimulation (DBS) programming program. This is the company’s latest listed funding event and brings its recorded funding total to $4 million across two grants; the earlier $1.9 million grant was announced on Sep 21, 2015. The company’s portfolio focuses on movement-disorder assessment and monitoring, including Kinesia ONE, Kinesia 360, and KinesiaU. Its patent portfolio includes 61 granted patents, and dated patent activity includes work on remote tuning of movement-disorder therapy systems and symptom assessment.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Great Lakes NeuroTechnologies distinct

  1. 01Combines wearable motion sensors, guided mobile assessments, and web-based reporting for remote motor-symptom monitoring.
  2. 02Uses clinically validated algorithms to generate objective symptom scores designed to correlate with expert clinician ratings.
  3. 03Supports both in-clinic and at-home assessments, with real-time data access for clinicians and researchers.
  4. 04Kinesia ONE is cleared for sale as a medical device in the United States, Europe, and Australia.
  5. 05Kinesia products are used as outcome measures in Phase I–IV clinical trials.

Technology & products5

  • Kinesia ONE

    A clinical assessment system for measuring motor symptoms in Parkinson’s disease and other movement disorders.

  • Kinesia 360

    A remote monitoring system for continuous assessment of motor symptoms in Parkinson’s disease patients.

  • KinesiaU

    A prescription medical app for patients to track Parkinson’s disease motor symptoms using smartphones and smartwatches.

Recent updates3

  • Jan 12, 2026Award

    Great Lakes NeuroTechnologies Awarded US Patent for Using AI to Measure Movement Disorder Symptoms and Adjust Treatment

    glneurotech.com
  • Aug 28, 2025Award

    Great Lakes NeuroTechnologies Awarded $2.1M NIH SBIR Grant for DBS Programming

    glneurotech.com
  • Apr 24, 2025Partnership

    Great Lakes NeuroTechnologies partners with Henry Schein Medical UK

    glneurotech.com

Funding

$4M disclosed
2 investors

Similar companies

About Great Lakes NeuroTechnologies

Products
Kinesia ONE, Kinesia 360, KinesiaU, BioRadio, RIP Band Interface Cable Chest
Leadership
Robert Schmidt, CEO and ChairmanDustin Heldman, President
Focus areas
NeuroTechnology, medical devices, digital health, wearables, research tools, clinical research, remote patient monitoring, movement disorders
Headquarters
Cleveland, Ohio
Founded
2010
Employees
11–50
Patents granted
61